NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Octocells

Octocells

Private
RouenHealthcare & Life Scienceshttps://www.octocells.com/

Last Round

Accelerator

Jan 31, 2025

Company Overview

Octocells is a biotechnology company that develops animal-free, three-dimensional cell culture technologies designed to enable scalable and reproducible cell growth for research and bioproduction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

3D cell cultureanimal-free bioscaffoldbioscaffoldingbioproductioncellular agriculturecultivated meatcell therapyscalable cell culturelab consumablespreclinical screeningdrug discoveryhyaluronic acid bioscaffoldlab-grown meatdigital twin

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Octocells Comps

Public and private peers based on sector, stage, and business model.

Octocells comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Octocells Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 31, 2025

Key People

Founding team and executive leadership

Grégory MAUBON

CTO And Cofounder

Founding Team

Zied Souguir

CEO

Executive Team

Octocells Investors

Notable investors and investment history

Octocells investors
InvestorRounds
3DEXPERIENCE LabAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2025

    Received funding from 3DEXPERIENCE Lab.

Octocells Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Octocells Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Octocells's valuation, stock price, and market status.

Firmographic Details

HeadquartersRouen
Employee Range1
Year Founded2022
Last FundingJan 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.